Alphabet's (GOOGL) Isomorphic raises USD 2bln for AI-designed drugs

Alphabet's Isomorphic securing $2 billion for AI-designed drugs signals a strong commitment to leveraging technology in pharmaceuticals. This could enhance Alphabet's value proposition and position in the healthcare sector, attracting interest from both investors and potential partners. The seriousness of their investment in AI could shift perceptions about the tech-firm's role in biotech, influencing related equities and sectors.